Corneal Cross-Linking for Keratoconus — Brisbane

What is corneal cross-linking?

A keratoconic cornea is weak. Its collagen fibres have too few of the natural bonds that hold a healthy cornea in shape, so under the pressure inside the eye it slowly bulges forward into a cone. Cross-linking adds those bonds back. Riboflavin (vitamin B2) drops are applied to the cornea and then activated with a precisely controlled dose of ultraviolet-A light. The reaction forms new cross-links between the collagen fibres, stiffening the cornea and locking in its shape.

It is a stabilising treatment. Cross-linking is designed to halt progression rather than to reverse the cone, although a degree of flattening is common and vision often improves modestly. For a bigger change in vision once the cornea is stable, it pairs well with CAIRS or topography-guided laser.

Who needs cross-linking?

Anyone whose keratoconus is progressing. Progression shows up as a prescription that keeps changing, a steepening corneal map between visits, or a cornea that is thinning. Because keratoconus moves fastest in the teens and twenties, this is often a treatment for young people, and the earlier it is done the more vision is preserved. There is no benefit in waiting to see how bad it gets; the vision lost to progression before treatment is not recovered by treatment.

Cross-linking is also used for other forms of corneal weakening, including pellucid marginal degeneration and ectasia after laser eye surgery. Dr Cronin assesses every patient with corneal topography and tomography, and where the cornea is already stable will say so rather than recommend a procedure that is not needed.

Epi-on cross-linking with Glaukos Epioxa

In the original cross-linking protocol the cornea's surface layer, the epithelium, is scraped away so that riboflavin can soak into the tissue beneath. It works, but the raw surface is what makes the first few days painful and the recovery slow. Epithelium-on ("epi-on") cross-linking leaves that layer in place. It relies on a riboflavin formulation that penetrates through the intact surface, supplemental oxygen delivered through goggles during treatment, and a stronger, pulsed UV-A protocol that keeps the reaction efficient.

The leading epi-on system is Glaukos Epioxa, which began life under the name Boost when the technology belonged to Avedro. Dr Cronin was the first surgeon in Australia to perform it, and has offered it in Brisbane for years while other centres waited. In October 2025 the US Food and Drug Administration approved Epioxa, the first incision-free cross-linking treatment to be approved there, on the strength of two randomised, double-masked Phase 3 trials that enrolled more than 400 patients and showed a statistically significant reduction in maximum corneal steepening at twelve months compared with sham treatment. Treatment was well tolerated, with more than nine in ten patients completing the year of follow-up (Glaukos, 2025).

For you, the difference is the recovery. No scraped surface means less pain, a lower risk of infection or haze, and a return to normal life in days rather than weeks.

Topography-guided cross-linking on the Glaukos Mosaic

Standard cross-linking treats the whole cornea with a single broad beam of light, even though the disease is concentrated in one area: the cone. Topography-guided, or customised, cross-linking uses your corneal map to design a UV pattern that delivers the most treatment where the cornea is steepest and weakest, applied by a programmable light source with eye tracking. The aim is greater flattening of the cone and a more regular corneal shape, which is what improves vision, rather than stiffening alone.

Dr Cronin performs this on the Glaukos Mosaic system. He was selected as one of fourteen surgeons globally for early access to the platform, which remains the only topography-guided cross-linking machine in Australia. Published evidence supports the approach: a prospective series of 42 eyes treated with epi-on, oxygen-supplemented, customised cross-linking reported improved uncorrected and corrected vision and significant corneal flattening at one year with no adverse events (Kamiya et al., J Clin Med 2020), and Dr Cronin's own one-year outcomes from Brisbane, combining Mosaic topography-guided treatment with oxygen goggles and pulsed epi-on irradiation, are published in the Journal of Cataract & Refractive Surgery (Cronin, Gunn & Chang, 2024). The headline finding from that series: customised topography-guided collagen cross-linking has a 60% chance of improving a patient's best corrected vision. Standard cross-linking is designed to stop progression; the customised pattern gives a real chance of seeing better as well.

Not every cornea needs the customised pattern, and Dr Cronin will recommend it where your maps show it will help. What matters is that the option exists here, and nowhere else in the country.

What happens on the day

Cross-linking is a day procedure, usually on a Thursday. For patients with private health insurance it is performed at an accredited day hospital with a specialist anaesthetist, lightly sedated or asleep. For patients without private cover, Dr Cronin has a dedicated outpatient procedure room at the Queensland Eye Institute, where the procedure is done under anaesthetic drops without a hospital admission. Either way, anaesthetic drops numb the eye, riboflavin is applied and given time to penetrate, the oxygen goggles are fitted, and the UV treatment is delivered to the planned pattern. The whole visit takes a couple of hours. A bandage contact lens is occasionally placed at the end, though most people do not need one, and you go home the same day with someone to drive you.

Recovery: back at work by Monday

Dr Cronin's post-operative protocol, developed at the Queensland Eye Institute, is built around one principle: stay ahead of the discomfort. The eye is sore for a few days, and it can take up to twelve hours after the procedure for that soreness to start, so you begin your pain relief before it does. Patients who follow the protocol typically report their worst pain as mild to moderate.

• Days 1 to 3: the eye is sore and sensitive to light; most people are more comfortable with both eyes closed and pass the time with music or audiobooks. Weak anaesthetic drops are used hourly as needed, alongside regular tablets.
• Time off: four days including the day of surgery. Operate Thursday, rest Friday and the weekend, back at work or school on Monday. Some people need a little longer; few need less.
• Drops: an antibiotic for one week, a steroid for three weeks, an anti-inflammatory for four days and lubricants for at least a month, with a tick-sheet so nothing is missed.
• Dryness: everyone has a dry eye for six to twelve weeks, usually felt as blur that clears on blinking. Lubricants make it pass faster.
• Contact lenses: from about two weeks, once the steroid drops stop. Glasses can be worn straight away.
• Driving: as soon as vision and comfort return, which ranges from a week to two months depending on whether you need lenses to see well.
• The rest: shower and wash your hair as normal, no swimming for three weeks, no eye make-up for a week, and no eye pad, shield or sunglasses required. Exercise resumes as soon as the pain has gone.

You are reviewed at one week and again at about a month. Emergencies after cross-linking are extremely rare, and Dr Cronin is contactable if anything worries you. The full handout is available to download: Collagen Cross-Linking post-operative instructions.

What results to expect

Vision fluctuates for the first six to eight weeks as the cornea remodels, then settles. Cross-linking itself changes the corneal shape, so scans in the first year move around; Dr Cronin does not count anything inside twelve months as progression. Beyond that, the cornea should be stable, and stability is the whole point: it protects the vision you have, gives your glasses or lenses a fixed target, and opens the door to vision-improving procedures such as CAIRS or the Athens protocol of topography-guided laser with cross-linking, both of which Dr Cronin offers. Where cross-linking does not hold, which is rare and usually linked to advanced disease, a very young patient or continued eye rubbing, it can be repeated.

Cost and Medicare

Cross-linking for progressive keratoconus attracts a Medicare rebate under item number 42652. With health-fund cover the procedure is done at the South Brisbane Day Hospital with no gap for the anaesthetist. Surgery fees in Australia typically range from $2,000 to $3,500 per eye before rebates, and you will receive an exact, itemised quote before booking.

No private health insurance? Dr Cronin has a dedicated outpatient procedure room at the Queensland Eye Institute so that cross-linking can be performed without a hospital admission. Because the procedure is then delivered out of hospital, it counts towards the Medicare Safety Net, which makes the procedure much cheaper for uninsured patients once the safety net threshold is reached. Ask the team which setting suits you when you book. The cross-linking cost guide explains what the fees cover and how the rebate applies.